Why Your Bloods Are Normal But You Feel Terrible
Why your bloods are normal but you feel terrible.
Standard blood panels are built to catch disease, not to measure how well you are working. Here is where the gap between ‘no disease’ and ‘not right’ usually lives — and what it takes to see it.
If your blood tests keep coming back ‘normal’ while you don’t feel right, two things are usually true at once. First, a result inside the reference range is not the same as a result that is good — reference ranges describe the statistical spread of the general population, not the level at which a high-functioning person operates well. Second, several of the systems that most often explain flat energy, broken sleep and dulled focus — the stress axis, the gut microbiome, the pace of biological ageing — are not measured on a standard panel at all.
So the report can be accurate and unhelpful in the same moment. It confirms there is no disease — which was never the question you were asking.
A reference range is statistical, not optimal — it describes the population, not the level your biology needs to perform.
Standard panels are built to detect disease; they are not designed to measure performance or spare capacity.
The stress (HPA) axis can be dysregulated while every marker on a standard panel still reads normal.
The gut microbiome shapes inflammation, immunity, mood and energy — and appears on no standard blood panel.
Biological age can run years ahead of chronological age — a gap invisible on a routine blood test.
What a ‘normal’ result actually means.
A reference range is built statistically. A large sample of people assumed to be healthy is measured, and the range is drawn to contain the central 95 per cent of them — everyone except the outer 2.5 per cent at each end.1 A result inside that band is flagged ‘normal’. This is exactly right for its purpose: identifying the people whose numbers have moved far enough to signal disease.
It is not built to identify a performance ceiling. ‘Normal’ is a statistical category, not a biological one. A vitamin D level near the bottom of the range is ‘normal’ — and also low enough that most people sitting there report poorer sleep, mood and energy. Both facts print on the same page. The reference range was never designed to resolve them; it was designed to find disease, and at that it works.
‘Normal’ tells you what is common in the population. It does not tell you what is optimal for you.
The systems a standard panel never sees.
Even a thorough blood panel samples a narrow set of markers from a few systems. Several of the systems that most determine how a high performer actually feels are not on it at all.
The stress axis is one. What carries the clinical signal is the shape of the cortisol curve across the day — high on waking, falling steadily, low at night. That curve can be flattened or reversed while a single morning cortisol draw still reads inside range.2 The gut microbiome is another: the community of organisms in the gut regulates inflammation and immune function,3 and through the gut–brain axis it influences mood, cognition and energy.4 It appears on no standard panel. Thyroid function is often only part-tested — free T3, the active hormone, sets much of the body’s metabolic pace.5 And biological age — how fast your body is actually ageing, read epigenetically — can run years ahead of the date on your licence,67 entirely invisible to a routine test.
Where ‘fine’ and ‘functioning’ part ways.
The space between ‘no disease’ and ‘operating well’ is wide, and it is measurable. Performance biology calibrates each marker not to where disease begins but to where the system works best — a narrower, more demanding window.
Low-grade inflammation shows the difference plainly: a high-sensitivity CRP can sit well inside the standard range and still be high enough to tax recovery and clarity.8 Fasting insulin behaves the same way, drifting upward inside ‘normal’ for years before blood glucose ever moves.9 Neither result is wrong. Each one answered a narrower question than the one you have.
Feeling terrible with normal bloods is not a contradiction. It is the predictable result of measuring for disease and then asking about performance.
Where the optimal window sits.
Performance biology calibrates each marker to where the body functions best, not where disease begins. The gap between the two is where most symptoms live.
| Marker | Performance range | What suboptimal levels typically indicate |
|---|---|---|
| Ferritin | 50–300 µg/L | Fatigue, low exercise capacity, hair shedding |
| Free T3 | 4.5–7 pmol/L | Thermal intolerance, cognitive sluggishness |
| Vitamin D | > 100 nmol/L | Mood lability, immune fragility, poor sleep |
| Fasting insulin | 3–4 mIU/L | Metabolic inflexibility, weight set-point drift |
| hs-CRP | < 1 mg/L | Low-grade inflammation, slow recovery |
| Homocysteine | 5–7.5 µmol/L | Methylation pressure, cardiovascular load |
The problem was real →
Both can be true at once. Usually, they are.
What the report left out.
A ‘normal’ blood result is statistically common, not biologically optimal.
Standard panels are built to detect disease — a narrower question than whether you are performing.
HPA-axis dysregulation, microbiome imbalance and accelerated biological ageing are common, and invisible on a standard panel.
A marker inside its reference range can still sit far from the level at which the system works well.
Feeling unwell with normal results is the measurable gap between ‘no disease’ and ‘functioning’ — not a contradiction.
Frequently asked.
What does ‘bloods normal but feel terrible’ actually mean?
It usually means one of two things, often both: the markers tested are inside the reference range but not at optimal levels, or the systems driving the symptoms — the stress axis, the gut microbiome, methylation, biological ageing — were never on the panel. The test is accurate; it simply answered a narrower question.
If my blood tests are normal, does that mean nothing is wrong?
Not necessarily. A normal panel reliably rules out the diseases it screens for. It does not confirm that every system is operating well — only that none has moved far enough to register as disease.
What gets tested that a standard blood panel doesn’t cover?
The shape of the cortisol curve across the day, the composition of the gut microbiome, epigenetic biological age, and a wider set of markers read against optimal rather than reference ranges — the systems that most often explain energy, sleep and focus.
Is the idea of an ‘optimal range’ supported by research?
Yes. For markers such as iron studies, thyroid hormones, vitamin D and inflammatory markers, the bands where most healthy people report sustained function are described in peer-reviewed literature, and are typically narrower than the laboratory reference range.
How long until I feel different once the right systems are addressed?
Fast-moving markers — lipids, inflammatory markers, thyroid — respond within eight to twelve weeks. The stress axis remodels across six to nine months. Microbiome and methylation shifts run on a six- to twelve-month timescale.
Performance biology, measured.
Elemental Protocol is a six-month functional-medicine protocol for high performers, followed by year-on-year measurement. Telehealth, Australia-wide. Apply to the program.
Apply to the programReferences.
- Ozarda Y. Reference intervals: current status, recent developments and future considerations. Biochemia Medica. 2016;26(1):5–16. doi.org/10.11613/BM.2016.001
- Adam EK, Quinn ME, Tavernier R, et al. Diurnal cortisol slopes and mental and physical health outcomes: a systematic review and meta-analysis. Psychoneuroendocrinology. 2017;83:25–41. doi.org/10.1016/j.psyneuen.2017.05.018
- Shi N, Li N, Duan X, Niu H. Interaction between the gut microbiome and mucosal immune system. Military Medical Research. 2017;4:14. doi.org/10.1186/s40779-017-0122-9
- Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nature Reviews Neuroscience. 2012;13(10):701–712. doi.org/10.1038/nrn3346
- Walczak K, Sieminska L. Obesity and thyroid axis. International Journal of Environmental Research and Public Health. 2021;18(18):9434. doi.org/10.3390/ijerph18189434
- Horvath S. DNA methylation age of human tissues and cell types. Genome Biology. 2013;14(10):R115. doi.org/10.1186/gb-2013-14-10-r115
- Levine ME, Lu AT, Quach A, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY). 2018;10(4):573–591. doi.org/10.18632/aging.101414
- Ridker PM. A test in context: high-sensitivity C-reactive protein. Journal of the American College of Cardiology. 2016;67(6):712–723. doi.org/10.1016/j.jacc.2015.11.037
- Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419. doi.org/10.1007/BF00280883
